Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

The combination of buspirone and bupropion in the treatment of depression.

Fava M.

Psychother Psychosom. 2007;76(5):311-2. No abstract available.

PMID:
17700052
[PubMed - indexed for MEDLINE]
2.

Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?

Clayton AH.

Expert Opin Pharmacother. 2007 Mar;8(4):457-66. Review.

PMID:
17309340
[PubMed - indexed for MEDLINE]
3.

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

Millan MJ.

Pharmacol Ther. 2006 May;110(2):135-370. Epub 2006 Mar 7. Review.

PMID:
16522330
[PubMed - indexed for MEDLINE]
4.

[Antidepressive pharmacotherapy: changing paradigms].

Bánki MC.

Neuropsychopharmacol Hung. 2004 Mar;6(1):1-3. Review. Hungarian. No abstract available.

PMID:
15125307
[PubMed - indexed for MEDLINE]
5.

Augmentation with buspirone: a review.

Harvey KV, Balon R.

Ann Clin Psychiatry. 1995 Sep;7(3):143-7. Review.

PMID:
8646275
[PubMed - indexed for MEDLINE]
6.

Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.

Pae CU, Lim HK, Han C, Patkar AA, Steffens DC, Masand PS, Lee C.

Expert Rev Neurother. 2007 Oct;7(10):1251-63. Review.

PMID:
17939764
[PubMed - indexed for MEDLINE]
7.

Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?

Doggrell SA.

Expert Opin Pharmacother. 2007 Dec;8(17):2903-15. Review.

PMID:
18001252
[PubMed - indexed for MEDLINE]
8.

Review: Bupropion and SSRI-induced side effects.

Demyttenaere K, Jaspers L.

J Psychopharmacol. 2008 Sep;22(7):792-804. doi: 10.1177/0269881107083798. Epub 2008 Feb 28. Review.

PMID:
18308785
[PubMed - indexed for MEDLINE]
9.

Bupropion and panic disorder: case report and review of the literature.

Serafini G, Pompili M, Fusar-Poli P, Porfiri G, Giordano G, Ferracuti S, Girardi P, Tatarelli R.

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):E47-50. doi: 10.1176/appi.neuropsych.23.2.E47. Review. No abstract available.

PMID:
21677228
[PubMed - indexed for MEDLINE]
10.

Bupropion: a review of its use in the management of major depressive disorder.

Dhillon S, Yang LP, Curran MP.

Drugs. 2008;68(5):653-89. Review. Erratum in: Drugs. 2008;68(7):980.

PMID:
18370448
[PubMed - indexed for MEDLINE]
11.

Spotlight on bupropion in major depressive disorder.

Dhillon S, Yang LP, Curran MP.

CNS Drugs. 2008;22(7):613-7. Review.

PMID:
18547129
[PubMed - indexed for MEDLINE]
12.

Naltrexone for the treatment of obesity: review and update.

Lee MW, Fujioka K.

Expert Opin Pharmacother. 2009 Aug;10(11):1841-5. doi: 10.1517/14656560903048959. Review.

PMID:
19537999
[PubMed - indexed for MEDLINE]
13.

Rhabdomyolysis associated with bupropion use as a smoking cessation adjunct: review of the literature.

Miladi A.

Mil Med. 2008 Oct;173(10):1042-3. Review.

PMID:
19160627
[PubMed - indexed for MEDLINE]
14.

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.

Papakostas GI.

J Clin Psychiatry. 2009;70 Suppl 6:16-25. doi: 10.4088/JCP.8133su1c.03. Review.

PMID:
19922740
[PubMed - indexed for MEDLINE]
15.

Clinical inquiries. What are the treatment options for SSRI-related sexual dysfunction?

Sturpe DA, Mertens MK, Scoville C.

J Fam Pract. 2002 Aug;51(8):681. Review. No abstract available.

PMID:
12184962
[PubMed - indexed for MEDLINE]
16.

The under-recognized role of dopamine in the treatment of major depressive disorder.

Montgomery SA.

Int Clin Psychopharmacol. 2008 Mar;23(2):63-9. doi: 10.1097/YIC.0b013e3282f2b3cb. Review.

PMID:
18301120
[PubMed - indexed for MEDLINE]
17.

Optimizing on smoke free legislation making the most of the opportunity.

Croghan E.

Br J Community Nurs. 2007 Aug;12(8):334-6. Review.

PMID:
17851296
[PubMed - indexed for MEDLINE]
18.

Combined treatments for major depression.

Joffe RT.

Expert Opin Investig Drugs. 2007 Sep;16(9):1379-89. Review.

PMID:
17714024
[PubMed - indexed for MEDLINE]
19.

Emerging drugs for major depressive disorder.

Kennedy SH, Rizvi SJ.

Expert Opin Emerg Drugs. 2009 Sep;14(3):439-53. doi: 10.1517/14728210903107751. Review.

PMID:
19637989
[PubMed - indexed for MEDLINE]
20.

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.

Peterson K, McDonagh MS, Fu R.

Psychopharmacology (Berl). 2008 Mar;197(1):1-11. Epub 2007 Nov 17. Review.

PMID:
18026719
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk